Inhibition of the contraction of the ductus arteriosus to oxygen by 1-aminobenzotriazole, a mechanism-based inactivator of cytochrome P450

British Journal of Pharmacology

Volumn 117, Issue 7, 1996, Pages 1586-1592

  Coceani, F ^a   Kelsey, L ^a   Seidlitz, E ^a   Korzekwa, K ^b,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

1 aminobenzotriazole; Cytochrome P450; Ductus arteriosus closure; Endothelin 1; Foetus; Oxygen

Indexed keywords

1 AMINOBENZOTRIAZOLE; CYCLIC GMP; CYTOCHROME P450; ENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DUCTUS ARTERIOSUS; FEMALE; GUINEA PIG; LAMB; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE TONE;

EID: 0029929344     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15325.x     Document Type: Article

References (40)

1. ANAND, K.J.S., YACOUB, M.H., BROWN, M.J., SIPPELL, W.G. & AYNSLEY-GREEN, A. (1985). Endocrine and metabolic regulation in term neonates (TN) undergoing cardiac surgery (CS) with cardiopulmonary bypass (CPB). Pediatr. Res., 19, 628.
2. BODACH E., COCEANI, F., DUMBRILLE, A., OKPAKO, D.T. & OLLEY, P.M. (1980). The response of the isolated ductus arteriosus to transmural stimulation and drugs. Br. J. Pharmacol., 71, 419-427.
3. BUTERS, J.T.M., KORZEKWA, K.R., KUNZE, K.L., OMATA, Y., HARDWICK, J.P. & GONZALEZ, F.J. (1994). cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug Metab. Dispos., 22, 688-692.
4. CAMPBELL, C.D. & REES, C.W. (1969). Reactive intermediates. Part 1. Synthesis and oxidation of 1- and 2-aminobenzotriazole. J. Chem. Soc., C, 742-747.
5. CLYMAN, R.I., BALLARD, P.L., SNIDERMAN, S., BALLARD, R.A., ROTH, R., HEYMANN, M.A. & GRANBERG, J.P. (1981A). Prenatal administration of betamethasone for prevention of patent ductus arteriosus. J. Pediatr., 98, 123-126.
6. CLYMAN, R.I., MAURAY, F., ROMAN, C., HEYMANN, M.A., BALLARD, P.L., RUDOLPH, A.M. & PAYNE, B. (1981b). Effects of antenatal glucocorticoid administration on ductus arteriosus of preterm lambs. Am. J. Physiol., 241, H415-H420.
7. 2. J. Pediatr., 98, 126-128.
8. COCEANI, F. (1994). Control of the ductus arteriosus - A new function for cytochrome P450, endothelin and nitric oxide. Biochem. Pharmacol., 48, 1315-1318.
9. COCEANI, F., BREEN, C.A., LEES, J.G., FALCK, J.R. & OLLEY, P.M. (1988). Further evidence implicating a cytochrome P-450-mediated reaction in the contractile tension of the lamb ductus arteriosus. Circ. Res., 62, 471-477.
10. COCEANI, F., HAMILTON, N.C., LABUC, J. & OLLEY, P.M. (1984). Cytochrome P450-linked monooxygenase: involvement in the lamb ductus arteriosus. Am. J. Physiol., 246, H640-H643.
11. 2 in prenatal patency of the lamb ductus arteriosus. Can. J. Physiol. Pharmacol., 64, 737-744.
12. COCEANI, F. & KELSEY, L. (1991). Endothelin-1 release from lamb ductus arteriosus: relevance to postnatal closure of the vessel. Can. J. Physiol. Pharmacol., 69, 218-221.
13. COCEANI, F., KELSEY, L., ACKERLEY, C., RABINOVITCH, M. & GELBOIN, H. (1994). Cytochrome P-450 during ontogenic development: occurrence in the ductus arteriosus and other tissues. Can. J. Physiol. Pharmacol., 72, 217-226.
14. COCEANI, F., KELSEY, L. & SEIDLITZ, E. (1992). Evidence for an effector role of endothelin in closure of the ductus arteriosus at birth. Can. J. Physiol. Pharmacol., 70, 1061-1064.
15. COCEANI, F., OLLEY, P.M., BISHAI, I., BODACH, E. & WHITE, E.P. (1978). Significance of the prostaglandin system to the control of muscle tone of the ductus arteriosus. In Prostaglandins and Perinatal Medicine, Advances in Prostaglandin and Thromboxane Research. Vol IV. ed. Coceani, F. & Olley, P.M. pp. 325-333, New York: Raven Press.
16. CRESPI, C.L. (1991). Expression of cytochrome p450 cDNAs in human B lymphoblastoid cells: applications to toxicology and metabolite analysis. Methods Enzymol., 206, 123-129.
17. DRAPER, R.L. (1920). The prenatal growth of the guinea-pig. Anat. Rec., 18, 369-392.
18. FAY, F.S. (1971). Guinea-pig ductus arteriosus. I. Cellular and metabolic basis for oxygen sensitivity. Am. J. Physiol., 221, 470-479.
19. FAY, F.S (1973). Biochemical basis for response of ductus arteriosus to oxygen. In Fetal and Neonatal Physiology, ed. Comline, K.S., Cross, K.W., Dawes, G.S. & Nathanielsz, P.W. pp. 136-140. Cambridge: Cambridge University Press.
20. FREEMAN, B.A. & CRAPO, J.D. (1982). Biology of disease. Free radicals and tissue injury. Lab. Invest., 47, 412-426.
21. GONZALEZ, F.J., AOYAMA, T. & GELBOIN, H.V. (1991). Expression of mammalian cytochrome p450 using vaccinia virus. Methods Enzymol., 206, 85-92.
22. GROGAN, J., SHOU, M., ZHOU, D., CHEN, S. & KORZEKWA, K.R. (1993). Use of aromatase (CYP19) metabolite ratios to characterize electron transfer from NADPH-cytochrome P450 reductase. Biochemistry, 32, 12007-12012.
23. HALPERT, J.R., GUENGERICH, F.P., BEND, J.R. & CORREIA, M.A. (1994). Contemporary issues in toxicology. Selective inhibitors of cytochromes P450. Toxicol. Appl. Pharmacol., 125, 163-175.
24. HUGHES, D., MURPHY, J.F., DYES, J., ROBINSON, J.A., RIAD-FAHMY, D. & HUGHES, I.A. (1987). Blood spot corticoid concentrations in ill preterm infants. Arch. Dis. Child., 62, 1014-1018.
25. IKEDA, M., RUBINSTEIN, E.H. & SONNENSCHEIN, R.R. (1973). Interaction of three factors in the closure of the ductus arteriosus. Proc. Soc. Exp. Biol. Med., 143, 354-359.
26. KIM, N., VARDI, Y., PADMA-NATHAN, H., DALEY, J., GOLDSTEIN, I. & SAENZ DE TEJADA, I (1993). Oxygen tension regulates the nitric oxide pathway. J. Clin. Invest., 91, 437-442.
27. KNICKLE, L.C. & BEND, J.R. (1992). Dose-dependent, mechanism-based inactivation of cytochrome P450 monooxygenases in vivo by 1-aminobenzotriazole in liver, lung, and kidney of untreated, phenobarbital-treated, and β naphthoflavone-treated guinea pigs. Can. J. Physiol. Pharmacol., 70, 1610-1617.
28. KNICKLE, L.C. & BEND, J.R. (1994). Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P4502B4 is solely responsible for formation of epoxyeicosatrienoic acids. Mol. Pharmacol., 45, 1273-1280.
29. LEEMANN, T., BONNABRY, P. & DAYER, P. (1994). Selective inhibition of major drug metabolizing cytochrome P450 isozymes in human liver microsomes by carbon monoxide. Life Sci., 54, 951-956.
30. MARKS, G.S., BRIEN, J.F., NAKATSU, K. & MCLAUGHLIN, B.E. (1991). Does carbon monoxide have a physiological function? Trends Pharmacol. Sci., 12, 185-188.
31. MATHEWS, J.A., DOSTAL, L.A. & BEND, J.R. (1985). Inactivation of rabbit pulmonary cytochrome P-450 in microsomes and isolated perfused lungs by the suicide substrate 1-aminobenzotriazole. J. Pharmacol. Exp. Ther., 235, 186-190.
32. NEEDLEMAN, P., TURK, J., JAKSCHIK, B.A., MORRISON, A.R. & LEFKOWITH, J.B. (1986). Arachidonic acid metabolism. Annu. Rev. Biochem., 55, 69-102.
33. ORTIZ DE MONTELLANO, P.R. & MATHEWS, J.M. (1981). Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole. Biochem. J., 195, 761-764.
34. RETTIE, A.E., WIENKERS, L.C., GONZALEZ, F.J., TRAGER, W.F. & KORZEKWA, K.R. (1994). Impaired (s)-warfarin metabolism catalyzed by the R144C allelic variant of CYP2C9. Pharmacogenetics, 4, 39-42.
35. SHOU, M., KORZEKWA, K.R., CRESPI, C.L., GONZALEZ, F.J. & GELBOIN, H.V. (1994). Metabolism of benzo[a]pyrene by seven cDNA expressed human cytochromes p450. Polycyclic Arom. Compounds, 7, 1-9.
36. 2 and fetal oxygen tension synergistically inhibit response of isolated fetal rabbit ductus arteriosus to norepinephrine. J. Cardiovasc. Pharmacol., 17, 861-866.
37. SOMLYO, A.V. & SOMLYO, A.P. (1964). Vasomotor function of smooth muscle in the main pulmonary artery. Am. J. Physiol., 206, 1196-1200.
38. WRIGHTON, S.A. & STEVENS, J.C. (1992). The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol., 22, 1-21.
39. YASUDA, N., KASUYA, Y., YAMADA, G., HAMA, H., MASAKI, T. & GOTO, K. (1994). Loss of contractile activity of endothelin-1 induced by electrical field stimulation-generated free radicals. Br. J. Pharmacol., 113, 21-28.
40. ZHOU, D., POMPON, D. & CHEN, S. (1990). Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening. Cancer Res., 50, 6949-6954.